Immune modulation with high-dose heat-schock protein gp96: Therapy of murine autoimmune diabetes and encephalomyelitis

International Immunology

Volumn 16, Issue 4, 2004, Pages 615-624

  Chandawarkar, Rajiv Y ^a   Wagh, Mihir S ^a   Kovalchin, Joseph T ^a   Srivastava, Pramod ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

CD25; CD4+ T cell; Suppressor T cell; Tolerance; Tumor immunity

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 96; HEAT SHOCK PROTEIN; INTERLEUKIN 2 RECEPTOR; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; DRUG MEGADOSE; FEMALE; HELPER CELL; IMMUNIZATION; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOTHERAPY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL TRANSPLANTATION; DIABETES MELLITUS, TYPE 1; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FIBROSARCOMA; GLYCOSURIA; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY, ACTIVE; INSULIN; LIPOPOLYSACCHARIDES; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MYELIN BASIC PROTEINS; MYELIN PROTEOLIPID PROTEIN; PANCREAS; PARALYSIS; PEPTIDE FRAGMENTS; RECEPTORS, INTERLEUKIN-2; SPLEEN; TIME FACTORS; TUMOR CELLS, CULTURED; VACCINATION;

EID: 1842854683     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh063     Document Type: Article

References (37)

1. Srivastava, P. 2002. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 20:395.
2. Blachere, N. E., Li, Z., Chandawarkar, R. Y., Suto, R., Jaikaria, N. S., Basu, S., Udono, H. and Srivastava, P. K, 1997. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J. Exp. Med. 186:1315.
3. Suto, R. and Srivastava, P. K. 1995. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269:1585.
4. Menoret, A., Chandawarkar, R. Y. and Srivastava, P. K. 2000. Natural autoantibodies against heat-shock proteins hsp70 and gp96: implications for immunotherapy using heat-shock proteins. Immunology 101:364.
5. Janetzki, S., Palla, D., Rosenhauer, V., Lochs, H., Lewis, J. J. and Srivastava, P. K. 2000. Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study. Int. J. Cancer 88:232.
6. Belli, F., Testori, A., Rivoltini, L., Maio, M., Andreola, G., Sertoli, M. R., Gallino, G., Piris, A., Cattelan, A., Lazzari, I., Carrabba, M., Scita, G., Santantonio, C., Pilla, L., Tragni, G., Lombardo, C., Arienti, F., Marchiano, A., Queirolo, P., Bertolini, F., Cova, A., Lamaj, E., Ascani, L., Camerini, R., Corsi, M., Cascinelli, N., Lewis, J. J., Srivastava, P. and Parmiani, G. 2002. Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. J. Clin. Oncol. 20:4169.
7. Chandawarkar, R. Y., Wagh, M. S. and Srivastava, P. K. 1999. The dual nature of specific immunological activity of tumor-derived gp96 preparations. J. Exp. Med. 189:1437.
8. Srivastava, P. K., DeLeo, A. B. and Old, L. J. 1986. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc. Natl Acad. Sci. USA 83:3407.
9. O'Connor, K. C., Bar-Or, A. and Hafler, D. A. 2001. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J. Clin. Immunol. 21:81.
10. Sobel, R. A., Greer, J. M. and Kuchroo, V. K. 1994. Minireview: autoimmune responses to myelin proteolipid protein. Neurochem. Res. 19:915.
11. Leiter, E. H. 1997. The NOD mouse: a model for insulin-dependent diabetes mellitus. Curr. Protocols Immunol. 24(Suppl.):15.9.1
12. + T cell levels in NOD mice. Proc. Natl Acad. Sci. USA 99:12287.
13. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431.
14. Srivastava, P. K. and Das, M. R. 1984. The serologically unique cell surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen. Int. J. Cancer 33:417.
15. Robert, J., Menoret, A., Basu, S., Cohen, N. and Srivastava, P. R. 2001. Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70. Eur. J. Immunol. 31:186.
16. Arnold, D., Faath, S., Rammensee, H. and Schild, H. 1995. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J. Exp. Med. 182:885.
17. Nieland, T. J., Tan, M. C., Monne-van Muijen, M., Koning, F., Kruisbeek, A. M. and van Bleek, G. M. 1996. Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94. Proc. Natl Acad. Sci. USA 93:6135.
18. Singh-Jasuja, H., Toes, R. E., Spee, P., Munz, C., Hilf, N., Sohoenberger, S. P., Ricciardi-Castagnoli, P., Neefjes, J., Rammensee, H. G., Arnold-Schild, D. and Schild, H. 2000. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J. Exp. Med. 191:1965.
19. Ishii, T., Udono, H., Yamano, T., Ohta, H., Uenaka, A., Ono, T., Hizuta, A., Tanaka, N., Srivastava, P. K. and Nakayama, E. 1999. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96. J. Immunol. 162:1303.
20. Breloer, M., Marti, T., Fleischer, B. and von Bonin, A. 1998. Isolation of processed, H-2Kb-binding ovalbumin-derived peptides associated with the stress proteins HSP70 and gp96. Eur. J. Immunol. 28:1016.
21. 1 stage of cell cycle. Cell. Immunol. 141:433.
22. Chakraborty, N. G., Twardzik, D. R., Sivanandham, M., Ergin, M. T., Hellstrom, K. E. and Mukherji, B. 1990. Autologous melanoma-induced activation of regulatory T cells that suppress cytotoxic response. J. Immunol. 145:2359.
23. + T cells and their roles in the induction and prevention of autoimmunity. Immunol. Rev. 123:37.
24. Binder, R. J, Han, D. K. and Srivastava, P. K. 2000. CD91: a receptor for heat shock protein gp96. Nat. Immunol. 1:151.
25. Basu, S., Binder, R. J., Ramalingam, T. and Srivastava, P. K. 2001. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14:303.
26. Panjwani, N. N., Popova, L., Febbraio, M. and Srivastava, P. K. 2000. The CD36 scavenger receptor as a receptor for gp96. Cell Stress Chaperone 5:391.
27. Vabulas, R. M., Wagner, H. and Schild, H. 2002. Heat shock proteins as ligands of toll-like receptors. Curr. Topics Microbiol. Immunol. 270:169.
28. Berwin, B., Hart, J. P., Pizzo, S. V. and Nicchitta, C. V. 2002. Cutting edge: CD91-independent crops-presentation of GRP94 (gp96)-associated peptides. J. Immunol. 168:4282.
29. More, S., Breloer, M., Fleischer, B. and von Bonin, A. 1999. Activation of cytotoxic T cells in vitro by recombinant gp96 fusion proteins irrespective of the 'fused' antigenic peptide sequence. Immunol. Lett. 69:275.
30. Breloer, M., Fleischer, B. and von Bonin, A. 1999. In vivo and in vitro activation of T cells after administration of Ag-negative heat shock proteins. J. Immunol. 162:3141.
31. Hilf, N., Singh-Jasuja, H., Schwarzmaier, P., Gouttefangeas, C. Rammensee, H. G. and Schild, H. 2002. Human platelets express heat shock protein receptors and regulate dendritic cell maturation. Blood 99:3676.
32. Radsak, M. P., Hilf, N., Singh-Jasuja, H., Braedel, S., Brossart, P., Rammensee, H. G. and Schild, H. 2003. The heat shock protein Gp96 binds to human neutrophils and monocytes and stimulates effector functions. Blood 101:2810.
33. Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T., Haba, T., Scherer, D. C., Wei, J., Kronenberg, M., Koezuka, Y. and Van Kaer, L. 2001. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7:1052.
34. Beaudoin, L., Laloux, V., Novak, J., Lucas, B. and Lehuen, A. 2002. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity 17:725.
35. - regulatory cells mediate dominant transplantation tolerance. J. Immunol. 168:5558.
36. - T cells in aged mice are hyporesponsive and exhibit suppressive activity. J. Immunol. 170:1675.
37. Frost, R. 1916. The Road Not Taken. Mountain Interval/Holt, New York.